Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy
暂无分享,去创建一个
H. Moser | E. Melhem | G. Raymond | A. Fatemi | D. Loes | A. Fatemi | N. Gupte | G. V. Raymond | D. J. Loes | E. R. Melhem | N. Gupte | L. Bezman | H. W. Moser | L. Bezman | H. Moser
[1] H. Moser,et al. Therapy of X-linked adrenoleukodystrophy: Prognosis based upon age and MRI abnormality and plans for placebo-controlled trials , 2000, Journal of Inherited Metabolic Disease.
[2] J. Pevsner,et al. X-Linked Adrenoleukodystrophy: Genes, Mutations, and Phenotypes , 2004, Neurochemical Research.
[3] H. Moser,et al. Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy , 2002, Neurology.
[4] H. Moser,et al. ABCD1 mutations and the X‐linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations , 2001, Human mutation.
[5] H. Moser,et al. The Dorsal Root Ganglia in Adrenomyeloneuropathy: Neuronal Atrophy and Abnormal Mitochondria , 2001, Journal of neuropathology and experimental neurology.
[6] H. Moser,et al. Evolution of phenotypes in adult male patients with X‐linked adrenoleukodystrophy , 2001, Annals of neurology.
[7] H. Moser,et al. X-Linked Adrenoleukodystrophy: Overview and Prognosis as a Function of Age and Brain Magnetic Resonance Imaging Abnormality. A Study Involving 372 Patients , 2000, Neuropediatrics.
[8] I. Jambaqué,et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy , 2000, The Lancet.
[9] K. Dusenbery,et al. The worldwide hematopoietic cell transplantation experience for cerebral x-adrenoleukodystrophy , 2000 .
[10] H. Moser,et al. X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression. , 2000, AJNR. American journal of neuroradiology.
[11] H. Moser,et al. Adrenomyeloneuropathy: A Neuropathologic Review Featuring Its Noninflammatory Myelopathy , 2000, Journal of neuropathology and experimental neurology.
[12] H. Moser,et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls , 1999, Annals of neurology.
[13] J. Frahm,et al. Quantitative Proton Magnetic Resonance Spectroscopy of Childhood Adrenoleukodystrophy , 1998, Neuropediatrics.
[14] B. Isberg,et al. Treatment of adrenoleukodystrophy with bone marrow transplantation , 1997, Acta paediatrica.
[15] J. Mandel,et al. Adrénoleucodystrophie liée à l'X , 2007 .
[16] J. Frahm,et al. Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients. , 1996, Pediatric neurology.
[17] J. Mandel,et al. A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Moser,et al. Multislice proton magnetic resonance spectroscopic imaging in X‐linked adrenoleukodystrophy , 1994, Annals of neurology.
[19] H. Moser,et al. Adrenoleukodystrophy: a scoring method for brain MR observations. , 1994, AJNR. American journal of neuroradiology.
[20] J. Mosser,et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. , 1994, Human molecular genetics.
[21] H. Moser,et al. The Inflammatory Myelinopathy of Adreno‐Leukodystrophy: Cells, Effector Molecules, and Pathogenetic Implications , 1992, Journal of neuropathology and experimental neurology.
[22] C Adamsbaum,et al. Brain MRI and electrophysiologic abnormalities in preclinical and clinical adrenomyeloneuropathy , 1992, Neurology.
[23] J. Chaussain,et al. MRI detects cerebral involvement in neurologically asymptomatic patients with adrenoleukodystrophy , 1989, Neurology.
[24] Charles R.scriver,et al. The Metabolic basis of inherited disease , 1989 .
[25] G. di Chiro,et al. A new CT pattern in adrenoleukodystrophy. , 1980, Radiology.